Targeted protein degradation: A promise for undruggable proteins

被引:153
作者
Samarasinghe, Kusal T. G. [1 ]
Crews, Craig M. [1 ,2 ,3 ]
机构
[1] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT 06511 USA
[2] Yale Univ, Dept Mol, New Haven, CT 06511 USA
[3] Yale Univ, Dept Pharmacol, New Haven, CT 06511 USA
关键词
CHEMICALLY-INDUCED DEGRADATION; TYROSINE KINASE ACTIVATION; BETA-CATENIN; SELECTIVE DEGRADATION; CHIMERIC MOLECULES; PROTAC DESIGN; CANCER; RESISTANCE; INHIBITORS; UBIQUITINATION;
D O I
10.1016/j.chembiol.2021.04.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Protein homeostasis, or "proteostasis," is indispensable for a balanced, healthy environment within the cell. However, when natural proteostasis mechanisms are overwhelmed from excessive loads of dysregulated proteins, their accumulation can lead to disease initiation and progression. Recently, the induced degradation of such disease-causing proteins by heterobifunctional molecules, i.e., PROteolysis TArgeting Chimeras (PROTACs), is emerging as a potential therapeutic modality. In the 2 decades since the PROTAC concept was proposed, several additional Targeted Protein Degradation (TPD) strategies have also been explored to target previously undruggable proteins, such as transcription factors. In this review, we discuss the progress and evolution of the TPD field, the breadth of the proteins targeted by PROTACs and the biological effects of their degradation.
引用
收藏
页码:934 / 951
页数:18
相关论文
共 50 条
  • [21] Exploiting Folding and Degradation Machineries To Target Undruggable Proteins: What Can a Computational Approach Tell Us?
    Serapian, Stefano A.
    Triveri, Alice
    Marchetti, Filippo
    Castelli, Matteo
    Colombo, Giorgio
    CHEMMEDCHEM, 2021, 16 (10) : 1593 - 1599
  • [22] Targeted protein degradation as a tumor suppressor
    Arat, Nezahat Ozlem
    Harrington, Lea
    CELL CYCLE, 2014, 13 (22) : 3473 - 3473
  • [23] Novel approaches to targeted protein degradation technologies in drug discovery
    Xue, Yu
    Bolinger, Andrew A.
    Zhou, Jia
    EXPERT OPINION ON DRUG DISCOVERY, 2023, 18 (04) : 467 - 483
  • [24] Major advances in targeted protein degradation: PROTACs, LYTACs, and MADTACs
    Alabi, Shanique B.
    Crews, Craig M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2021, 296 (296)
  • [25] Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation
    He, Ming
    Lv, Wenxing
    Rao, Yu
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [26] From PROTAC to TPD: Advances and Opportunities in Targeted Protein Degradation
    Wang, Siqi
    He, Fuchu
    Tian, Chunyan
    Sun, Aihua
    PHARMACEUTICALS, 2024, 17 (01)
  • [27] PROTAC: An Effective Targeted Protein Degradation Strategy for Cancer Therapy
    Qi, Si-Min
    Dong, Jinyun
    Xu, Zhi-Yuan
    Cheng, Xiang-Dong
    Zhang, Wei-Dong
    Qin, Jiang-Jiang
    FRONTIERS IN PHARMACOLOGY, 2021, 12
  • [28] Targeted protein degradation as an antiviral approach
    Chakravarty, Antara
    Yang, Priscilla L.
    ANTIVIRAL RESEARCH, 2023, 210
  • [29] Chemical Inducers of Targeted Protein Degradation
    Raina, Kanak
    Crews, Craig M.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (15) : 11057 - 11060
  • [30] Targeted protein degradation and drug discovery
    Naito, Mikihiko
    JOURNAL OF BIOCHEMISTRY, 2022, : 61 - 69